4D Molecular Therapeutics, Inc.

FDMT

—

Advanced chart & tools →

4D Molecular Therapeutics, Inc.FDMT

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-2.42

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$85.21M

Net income

$-140.11M

Net margin

-164.4%

Gross margin

—

Dividends & financials

4D Molecular Therapeutics, Inc. (FDMT) reported revenue of $85.21M and net income of $-140.11M, or $-2.42 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.